# Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.

> **NCT00766038** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 63 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Recombinant human Growth Hormone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00766038
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-12
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2019-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766038, "Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00766038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*